Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EnClear Therapies logo — CSF based Therapies, Delivery and Diagnostics

EnClear Therapies

CSF based Therapies, Delivery and Diagnostics

Founded 2018 United States Newburyport, United States 12 employees Venture round Total: $12.72M Biotechnology, Health and Wellness

General Information

Company Name EnClear Therapies
Founded Year 2018
Location United States Newburyport, United States
Employees 12
Industries Biotechnology, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with EnClear Therapies. To contact EnClear Therapies, visit encleartherapies.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About EnClear Therapies

EnClear Therapies, a biotechnology startup founded in 2018 in the United States, is focused on developing CSF-based therapies, delivery, and diagnostics, with the slogan "CSF-based Therapies, Delivery and Diagnostics." The company's mission is to leverage bioscience and med-tech expertise to enhance the lives of patients with CNS diseases. At EnClear Therapies, the team is dedicated to creating systems and medical interventions that Access, Recirculate & Modify CSF for targeted removal of toxicity linked to neurodegenerative disease progression and continuous localized delivery of therapeutics. In March 2024, the company secured a $718.33K Venture Round investment, showcasing investor confidence in its innovative approach. The intersection of biotechnology and CNS disease treatment presents an exciting growth opportunity, and EnClear Therapies is well-positioned to make a meaningful impact in this space. The recent investment underscores the potential of the company's approach, signaling a promising trajectory for EnClear Therapies as it continues to advance its groundbreaking solutions.

Taxonomy: EnClear Therapies, CSF based therapies, Bioscience, Med-tech, CNS disease, Neurodegenerative disease, Toxicity removal, Medical interventions, CSF recirculation, Therapeutics delivery, Personalized therapy, Continuous monitoring, Medical technology, Neuroscience, Healthcare innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $718.33K -
01 Mar 2024
Series A $10.00M 10
20/20 HealthCare Partners Amgen Ventures Dolby Ventures
20/20 HealthCare Partners, Amgen Ventures +8
19 Feb 2020
Seed Round $2.00M -
14 Mar 2019
Seed Round Undisclosed -
01 Mar 2019

EnClear Therapies Alternatives & Competitors

View All Alternatives
EnClear Therapies vs
BIORCHESTRA Co., Ltd.
BIORCHESTRA Co., Ltd. United States

We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurod...

Series C
16 employees
Biopharma, Biotechnology
EnClear Therapies vs
T-NeuroPharma
T-NeuroPharma United States

Using T-Cells to Track and Treat Neurodegenerative Diseases

Grant
6 employees
Biotechnology, Health Care
EnClear Therapies vs
Fractyl Health
Fractyl Health United States

Dedicated to novel therapies that can sustain long term weight management.

Series F
104 employees
Biotechnology, Health Care
View all alternatives

FAQ About EnClear Therapies

CSF based Therapies, Delivery and Diagnostics
EnClear Therapies was founded in 2018.
EnClear Therapies is headquartered in Newburyport, United States.
EnClear Therapies operates in Biotechnology and Health and Wellness. Its work centres on EnClear Therapies, CSF based therapies, Bioscience and Med-tech.
EnClear Therapies has approximately 12 employees.
EnClear Therapies has completed 4 funding rounds, raising a total of $12.72M. The latest funding stage is Venture round.
Top alternatives and competitors to EnClear Therapies include BIORCHESTRA Co., Ltd., T-NeuroPharma, Fractyl Health, Tesu Health, Tivic Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EnClear Therapies and BIORCHESTRA Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EnClear Therapies, https://bouncewatch.com/company/enclear-therapies, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes